Tao Gong Selected Research

ungeremine (AT 1840)

1/2018	A comparison study between lycobetaine-loaded nanoemulsion and liposome using nRGD as therapeutic adjuvant for lung cancer therapy.
8/2017	nRGD modified lycobetaine and octreotide combination delivery system to overcome multiple barriers and enhance anti-glioma efficacy.
1/2013	Nanoemulsion loaded with lycobetaine-oleic acid ionic complex: physicochemical characteristics, in vitro, in vivo evaluation, and antitumor activity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tao Gong Research Topics

Disease

110	Neoplasms (Cancer) 04/2024 - 06/2008
23	Breast Neoplasms (Breast Cancer) 02/2024 - 01/2015
23	Inflammation (Inflammations) 02/2024 - 02/2009
21	Neoplasm Metastasis (Metastasis) 02/2024 - 02/2014
12	Melanoma (Melanoma, Malignant) 01/2024 - 11/2014
10	Infections 01/2023 - 03/2010
9	Fibrosis (Cirrhosis) 09/2023 - 04/2020
9	Hepatocellular Carcinoma (Hepatoma) 01/2023 - 08/2010
8	Atherosclerosis 01/2023 - 01/2018
8	Rheumatoid Arthritis 01/2023 - 01/2017
7	Colorectal Neoplasms (Colorectal Cancer) 02/2024 - 11/2017
7	Dental Caries (Decay, Dental) 02/2024 - 03/2019
7	Ischemic Stroke 01/2024 - 01/2017
7	Glioma (Gliomas) 01/2023 - 02/2011
6	Reperfusion Injury 07/2023 - 10/2014
6	Lung Neoplasms (Lung Cancer) 06/2023 - 01/2012
6	Liver Neoplasms (Liver Cancer) 05/2022 - 08/2010
6	Parkinson Disease (Parkinson's Disease) 10/2021 - 09/2014
5	Hemolysis 01/2024 - 02/2014
5	Brain Ischemia (Cerebral Ischemia) 07/2023 - 01/2017
5	Alzheimer Disease (Alzheimer's Disease) 01/2018 - 05/2009
4	Liver Cirrhosis (Hepatic Cirrhosis) 02/2024 - 01/2019
4	Carcinogenesis 02/2024 - 05/2019
4	Body Weight (Weight, Body) 02/2024 - 06/2014
4	Wounds and Injuries (Trauma) 01/2024 - 01/2018
4	Pathologic Constriction (Stenosis) 04/2023 - 12/2002
4	COVID-19 01/2023 - 01/2020
4	Thrombosis (Thrombus) 01/2021 - 04/2017
3	Hypoxia (Hypoxemia) 12/2023 - 02/2022
3	Carcinoma (Carcinomatosis) 12/2023 - 05/2009
3	Stroke (Strokes) 10/2023 - 01/2019
3	Hyperplasia 09/2023 - 01/2022
3	Brain Neoplasms (Brain Tumor) 08/2023 - 04/2014
3	Cardiovascular Diseases (Cardiovascular Disease) 08/2022 - 01/2019

Drug/Important Bio-Agent (IBA)

19	Liposomes (Liposome)IBA 01/2024 - 04/2013
17	MicellesIBA 02/2024 - 11/2011
17	Proteins (Proteins, Gene)FDA Link 02/2024 - 02/2014
14	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2024 - 10/2014
12	Peptides (Polypeptides)IBA 02/2024 - 02/2015
12	Hyaluronic Acid (Hyaluronan)IBA 03/2021 - 01/2015
11	Biomarkers (Surrogate Marker)IBA 01/2024 - 01/2018
11	Paclitaxel (Taxol)FDA LinkGeneric 02/2023 - 11/2014
11	Therapeutic UsesIBA 01/2023 - 01/2013
10	CytokinesIBA 11/2023 - 10/2014
10	gamma-Aminobutyric Acid (GABA)IBA 10/2021 - 02/2017
9	Phospholipids (Phosphatides)FDA LinkGeneric 02/2024 - 06/2014
9	Chondroitin Sulfates (Chondroitin Sulfate)IBA 02/2024 - 01/2019
9	PolymersIBA 04/2023 - 11/2008
8	AlbuminsIBA 02/2024 - 09/2019
8	LipidsIBA 02/2024 - 01/2012
8	Protons (Proton)IBA 10/2023 - 01/2017
7	pirarubicinIBA 02/2024 - 10/2013
7	Human Serum Albumin FDA LinkGeneric 07/2023 - 10/2013
7	Lipid NanoparticlesIBA 03/2023 - 08/2010
7	LigandsIBA 01/2022 - 08/2015
6	celastrolIBA 02/2024 - 05/2019
6	EnzymesIBA 02/2024 - 04/2013
6	AntigensIBA 12/2023 - 02/2015
6	CollagenIBA 09/2023 - 02/2020
6	InflammasomesIBA 10/2021 - 12/2014
5	SolutionsIBA 04/2024 - 01/2015
5	Antineoplastic Agents (Antineoplastics)IBA 02/2024 - 01/2014
5	AmidesIBA 10/2023 - 01/2017
5	MicroRNAs (MicroRNA)IBA 03/2023 - 01/2012
5	ChemokinesIBA 01/2023 - 10/2014
5	SaltsIBA 01/2023 - 06/2022
5	Fibronectins (Fibronectin)IBA 01/2023 - 01/2017
5	AcidsIBA 01/2023 - 02/2015
5	CholesterolIBA 07/2021 - 03/2016
4	Long Noncoding RNAIBA 02/2024 - 01/2020
4	CyclodextrinsIBA 02/2024 - 01/2016
4	ProdrugsIBA 12/2023 - 05/2009
4	InterferonsIBA 03/2023 - 10/2017
4	AntioxidantsIBA 03/2023 - 05/2010
4	Bovine Serum AlbuminIBA 01/2023 - 02/2014
3	Glucose (Dextrose)FDA LinkGeneric 02/2024 - 01/2016
3	Photosensitizing Agents (Photosensitizers)IBA 02/2024 - 01/2022
3	Immunologic Factors (Immunomodulators)IBA 02/2024 - 11/2022
3	1-phenyl-3,3-dimethyltriazene (PDT)IBA 02/2024 - 01/2022
3	Immune Checkpoint InhibitorsIBA 01/2024 - 10/2021
3	Phenobarbital (Luminal)FDA Link 01/2024 - 09/2020
3	Folic Acid (Vitamin M)FDA LinkGeneric 04/2023 - 10/2021
3	graphene oxideIBA 04/2023 - 01/2019
3	Transforming Growth Factors (Transforming Growth Factor)IBA 03/2023 - 10/2017
3	Silybin (Lagosa)IBA 02/2023 - 04/2020
3	Palmitic Acid (Hexadecanoic Acid)IBA 02/2023 - 11/2020
3	SodiumIBA 01/2023 - 06/2022
3	Indicators and Reagents (Reagents)IBA 12/2022 - 01/2021
3	Amino Acids FDA Link 10/2022 - 06/2021

Therapy/Procedure

61	Therapeutics 04/2024 - 12/2002
22	Drug Therapy (Chemotherapy) 02/2024 - 02/2007
12	Immunotherapy 02/2024 - 02/2015
11	Injections 02/2024 - 01/2012
6	Stents 09/2023 - 02/2007
5	Photothermal Therapy 04/2024 - 10/2021
3	Photochemotherapy (Photodynamic Therapy) 02/2024 - 01/2022
3	Intravenous Administration 07/2023 - 11/2011
3	Dietary Approaches To Stop Hypertension 01/2023 - 06/2022
3	Lasers (Laser) 10/2021 - 05/2009
3	Intravenous Injections 07/2021 - 01/2013